"Indapamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
| Descriptor ID |
D007190
|
| MeSH Number(s) |
D02.065.884.540 D02.886.590.700.540 D03.633.100.473.391
|
| Concept/Terms |
S-1520- S-1520
- S 1520
- S1520
- SE-1520
- SE 1520
- SE1520
|
Below are MeSH descriptors whose meaning is more general than "Indapamide".
Below are MeSH descriptors whose meaning is more specific than "Indapamide".
This graph shows the total number of publications written about "Indapamide" by people in this website by year, and whether "Indapamide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Indapamide" by people in Profiles.
-
Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus. Hypertension. 2014 Feb; 63(2):220-1.
-
Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes. Ann Intern Med. 2008 Mar 04; 148(5):400-1.
-
Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial. Pol Arch Med Wewn. 2007 Sep; 117(9):389-90.
-
A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J Clin Pharmacol. 1991 Aug; 31(8):751-7.